The Woodlands, TX, United States of America

Mary Lapadat-Tapolsky


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mary Lapadat-Tapolsky: Innovator in Anti-Proliferative Factors

Introduction

Mary Lapadat-Tapolsky is a notable inventor based in The Woodlands, TX (US). She has made significant contributions to the field of cancer research through her innovative work on anti-proliferative factors. Her research focuses on identifying factors that can inhibit cell growth, which is crucial in the treatment of cancers and other hyperproliferative diseases.

Latest Patents

Mary Lapadat-Tapolsky holds a patent titled "Inhibition of cell growth by an anti-proliferative factor." This invention involves the identification of factors that are anti-proliferative and can be utilized in treating various diseases. The factors are induced from cells following contact with viral or plasmid expression vectors. One of the identified factors is between about 3 kDa and 300 kDa in size, while another is less than about 3 kDa. Both factors are heat stable and resistant to protease and nuclease treatment. The patent also discloses methods for purification and use of these factors.

Career Highlights

Mary is affiliated with the University of Texas System, where she continues her research and development in the field of anti-proliferative factors. Her work has the potential to impact cancer treatment significantly, providing new avenues for therapeutic interventions.

Collaborations

Mary has collaborated with notable colleagues, including Deborah R Wilson and Therese M Timmons. These collaborations enhance the research efforts and contribute to the advancement of knowledge in the field.

Conclusion

Mary Lapadat-Tapolsky is a pioneering inventor whose work on anti-proliferative factors holds promise for cancer treatment. Her contributions to the field are invaluable, and her patent reflects her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…